PP13, maternal ABO blood groups and the risk assessment of pregnancy complications (scientific article (publication date: 2011))

Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP13), a new lysophospholipase, homologue of human eosinophil Charcot-Leyden Crystal protein

Q22010697

A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death

Q24317162

Functional analyses of placental protein 13/galectin-13

Q28249207

Galectins: regulators of acute and chronic inflammation

Q28272886

Purification and characterization of two new soluble placental tissue proteins (PP13 and PP17)

Q28275001

Innate immune lectins kill bacteria expressing blood group antigen

Q30494049

PP13 mRNA expression in trophoblasts from preeclamptic placentas

Q33393566

Proliferative versus hypertrophic growth in tissue subcompartments of human placental villi during gestation.

Q34087350

The relationship between ABO histo-blood group, factor VIII and von Willebrand factor.

Q34088875

Homology modelling and molecular dynamics studies of human placental tissue protein 13 (galectin-13).

Q34104978

The effect of ABO blood group on the diagnosis of von Willebrand disease.

Q34180946

Molecular genetic basis of the histo-blood group ABO system.

Q34323307

Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies.

Q34326623

ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world

Q34346443

First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction

Q34647428

The sugar code: functional lectinomics

Q34837784

Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions

Q35015992

Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin.

Q35138418

Placental protein 13 (PP13/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome.

Q36480074

Carbohydrate recognition systems in autoimmunity.

Q36687913

Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens

Q36741513

Emergence of hormonal and redox regulation of galectin-1 in placental mammals: implication in maternal-fetal immune tolerance

Q36915292

The two stage model of preeclampsia: variations on the theme

Q37187589

Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia

Q37198421

ABO blood group glycans modulate sialic acid recognition on erythrocytes

Q37398333

Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome.

Q37416997

First-trimester maternal serum PP13 in the risk assessment for preeclampsia.

Q37444801

Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar

Q37567589

Immunology of pre-eclampsia

Q37717752

Factor VIII and von Willebrand factor--too sweet for their own good

Q37768888

Associations between human red cell blood group antigens and disease

Q37846410

Structure and functional analysis of the fungal galectin CGL2.

Q38342886

Determination of carbohydrate-binding preferences of human galectins with carbohydrate microarrays

Q38343057

Fetal growth rate and its variations 1988/89

Q43523616

Blood Groups, Myocardial Infarction and Angina Pectoris among 10,000 Adult Males

Q44056121

Genetic thrombophilias and preeclampsia: a meta-analysis

Q45206281

Blood group AB and factor V Leiden as risk factors for pre-eclampsia: a population-based nested case-control study

Q46334817

A pivotal role for galectin-1 in fetomaternal tolerance

Q46891030

Birth weight standards in the live-born population in Israel

Q47381108

Increased frequency of genetic thrombophilia in women with complications of pregnancy

Q47868847

First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk

Q47872838

Prenatal medicine: the child is the father of the man. 1996.

Q48480846

The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP).

Q53314217

The ABO blood group system: historical background.

Q53475062

ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study

Q57300709

Maternal serum placental protein 13 at 11â 13 weeks of gestation in preeclampsia

Q61847857

Longitudinal Determination of Serum Placental Protein 13 during Development of Preeclampsia

Q61865449

Quantitative flow cytometric analysis of ABO red cell antigens

Q67812574

Case-control study of maternal blood group and severe pre-eclampsia

Q70791791

A United States national reference for fetal growth

Q70895060

Flow cytofluorimetric analysis of young and senescent human erythrocytes probed with lectins. Evidence that sialic acids control their life span

Q71578660

Factor VIII, ABO blood group and the incidence of ischaemic heart disease

Q72403298

Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis

Q72414738

Cigarette smoking in pregnancy and risk of pre-eclampsia

Q72472197

Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy

Q74090763

Does endothelial cell activation occur with intrauterine growth restriction?

Q74503868

First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia

Q79409207

Pre-eclampsia

Q81446389

A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound

Q82068160

First-trimester markers for the prediction of pre-eclampsia in women with a-priori high risk

Q82486507

Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study

Q82737458

PP13 as a marker of pre-eclampsia: A two platform comparison study

Q83269636

PP13 mRNA expression in the cellular component of maternal blood as a marker for preeclampsia

Q84669835

First‐trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early‐onset pre‐eclampsia

Q85029222

P275

Creative Commons Attribution 4.0 International

copyrighted

issue

language of work or name

English

Q1860

P304

page(s)

e21564

P577

publication date

2011-01-01

P1433

published in

PLOS One

Q564954

P1476

title

PP13, maternal ABO blood groups and the risk assessment of pregnancy complications

P478

volume

Reverse relations

cites work (P2860)

Q43976016	ABO and RhD blood groups and gestational hypertensive disorders: a population-based cohort study
Q33646081	Association between ABO and Rh Blood Groups and Risk of Preeclampsia: A Case-Control Study from Iran
Q36357099	Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?
Q38209381	Clinical applications of biomarkers in preeclampsia
Q34372600	Evolutionary origins of the placental expression of chromosome 19 cluster galectins and their complex dysregulation in preeclampsia
Q28081459	Galectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and Neoplasia
Q26823092	Galectins: guardians of eutherian pregnancy at the maternal-fetal interface
Q36927599	Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of 426 high-risk patients including ethical aspects
Q38080626	Novel biomarkers for predicting intrauterine growth restriction: a systematic review and meta-analysis
Q42373442	Personalized Therapy Against Preeclampsia by Replenishing Placental Protein 13 (PP13) Targeted to Patients With Impaired PP13 Molecule or Function
Q55692173	Pharmacokinetics of placental protein 13 after intravenous and subcutaneous administration in rabbits.
Q91638842	Placental Galectins Are Key Players in Regulating the Maternal Adaptive Immune Response
Q26861380	Placental Protein 13 (PP13) - A Placental Immunoregulatory Galectin Protecting Pregnancy
Q38969936	Placental Protein 13 Administration to Pregnant Rats Lowers Blood Pressure and Augments Fetal Growth and Venous Remodeling
Q64112776	Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration
Q50992588	Placental protein 13 (PP13)-induced vasodilation of resistance arteries from pregnant and nonpregnant rats occurs via endothelial-signaling pathways.
Q55689583	Placental protein 13: An important biological protein in preeclampsia.
Q50879778	Predicting the Risk to Develop Preeclampsia in the First Trimester Combining Promoter Variant -98A/C of LGALS13 (Placental Protein 13), Black Ethnicity, Previous Preeclampsia, Obesity, and Maternal Age.
Q92970986	Pregnancy Galectinology: Insights Into a Complex Network of Glycan Binding Proteins
Q64945574	Proteomic identification of membrane-associated placental protein 4 (MP4) as perlecan and characterization of its placental expression in normal and pathologic pregnancies.
Q26749607	Relationship between ABO blood group and pregnancy complications: a systematic literature analysis
Q58560479	Resetting the ligand binding site of placental protein 13/galectin-13 recovers its ability to bind lactose
Q33981931	Retracted: The Role of the Carbohydrate Recognition Domain of Placental Protein 13 (PP13) in Pregnancy Evaluated with Recombinant PP13 and the DelT221 PP13 Variant
Q37992519	The hypothesis on function of glycosphingolipids and ABO blood groups revisited

P819	ADS bibcode	2011PLoSO...621564T
P356	DOI	10.1371/JOURNAL.PONE.0021564
P932	PMC publication ID	3143125
P698	PubMed publication ID	21799738
P5875	ResearchGate publication ID	51531142